Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

50.69
Delayed Data
As of Jul 31
 -0.08 / -0.16%
Today’s Change
39.28
Today|||52-Week Range
51.74
+12.59%
Year-to-Date

Today’s Trading

Previous close50.77
Today’s open51.07
Day’s range-- - --
Volume5,573,486
Average volume (3 months)4,961,503
Market cap$75.5B
Dividend yield1.89%
Data as of 07/31/2015

Growth & Valuation

Earnings growth (last year)-8.61%
Earnings growth (this year)-5.00%
Earnings growth (next 5 years)+9.95%
Revenue growth (last year)-7.33%
P/E ratio38.0
Price/Sales3.40
Price/Book3.55

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.05+0.15%
VRXValeant Pharmaceutic...+3.25+1.28%
LLYEli Lilly and Co-0.03-0.04%
SHPGShire+4.29+1.63%
Data as of 07/31/2015

Financials

Next reporting dateOctober 21, 2015
EPS forecast (this quarter)$0.54
Annual revenue (last year)$20.2B
Annual profit (last year)$2.3B
Net profit margin8.50%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
VP-Investor Relations
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts